
Carl Borrebaeck
Professor

Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information?
Author
Summary, in English
Proteomics has not delivered biomarkers of clinical value, despite massive efforts. The technologies that are emerging today have, however, the power to reach deep into proteomes and to identify patterns associated with different diseases. The study design is then crucial and sample quality, bioinformatic approaches, pre-validation, using independent patient cohort, need to attract increased attention before proteomics will contribute to the needs of personalized medicine.
Department/s
- Department of Immunotechnology
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publishing year
2012
Language
English
Pages
343-345
Publication/Series
Proteomics Clinical Applications
Volume
6
Issue
7-8
Document type
Journal article
Publisher
John Wiley & Sons Inc.
Topic
- Cell and Molecular Biology
Keywords
- over-fitting
- biobanks
- pre-validation
- bioinformatics
- Signatures
Status
Published
ISBN/ISSN/Other
- ISSN: 1862-8354